OMRON proposes to acquire Matsuya R&D at ¥1110/share via OMRON Healthcare (¥904.0000, 0)
Japan October retail sales +1.7% y/y, seasonally-adjusted retail sales +1.6% m/m
StreetAccount Summary - Trading higher/lower: Asia mid-morning
StreetAccount Metrics Recap - OMRON Q2 Earnings (¥4248.0000, 0)
OMRON provides medium-term roadmap 2nd stage; guides FY30 ROE 10-12% (¥4248.0000, 0)
Powered by FactSet Research Systems Inc.